http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017239508-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_821a6739093a95150d2980c6da6a2d3b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24
filingDate 2017-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7e0c47c521d999b6d474557908c0b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507e55e939c8a1b848ac20e210452ebf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fe3860ae749d6119698b260cc8c074
publicationDate 2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2017239508-B2
titleOfInvention Pantothenate derivatives for the treatment of neurologic disorders
abstract ll:\sxd\Interw ovn\NRPortbl\DCC\SXD\15763550 l.docx-28092017 The present disclosure relates to pantothenate derivatives for the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders. OR" R'O 0 R R' R" (Amino Acid) Me (L-Ala) Me Me Me (L-Ala) Et Bn Me (L-Ala) MeCyPr MeCyPr Melndole (L-Trp) Bn Et
priorityDate 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430582731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467250615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467167502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129636772

Total number of triples: 35.